People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...

As she awaited a heart ablation to treat her AFib, Dolores Catania turned to food for comfort. After her procedure, she ...

According to a new feature by the Washington Post, approximately 16 million American adults are on GLP-1 drugs such as ...

The late-stage readout suggests that HRS9531 can hold its own against Eli Lilly’s blockbuster GLP-1/GIP agonist Zepbound, ...

The molecule, developed in collaboration with Massachusetts-based Kailera Therapeutics, is headed for a new drug application ...

Medication paired with behavioral change support gives employers the opportunity to provide a more well-rounded approach to ...

Lotte Bjerre Knudsen, Chief Scientific Adviser for Research at Danish pharma giant Novo Nordisk, speaks about GLP-1-based ...

Q: I used to be a serious exerciser, but now that I am in my late 60s, I find it harder and harder to stay on track. Got any words ...

Prediabetes is associated with a nearly 4-fold higher risk of MASLD. (1) Approximately 33% of Indian adults have prediabetes. (2) The burden of MASLD ...

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are reporting. In very rare cases they can be deadly. Here’s what to know.

The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are ...